Introduction
Cortical visual impairment (CVI), also known as cerebral or brain-based visual impairment, is the leading cause of paediatric visual impairment in high-income countries and is increasing in low-income nations,1 accounting for an estimated 20%–48% of cases.2–4 CVI is diagnosed in children with visual deficits due to damage to postgeniculate visual pathways in the brain, rather than the eye.5 Common causes include hypoxic–ischaemic encephalopathy, prematurity with periventricular leucomalacia, hydrocephalus, trauma, seizures, structural brain abnormalities and genetic syndromes.1 6 Although children with CVI may have ocular comorbidities, the visual dysfunction is worse than expected for the degree of ocular pathology. Traditionally, decreased visual acuity and visual field deficits are required for diagnosis of CVI, but some practitioners diagnose CVI in patients with higher-level visual processing abnormalities only.7
Because of involvement of central visual pathways, children with CVI frequently exhibit characteristic visual behaviours and deficits that differ from children with ocular causes of visual impairment.8 9 These behaviours were first described by Jan et al in 1987 and include variable visual function (dependence on environmental factors, fatigue, illness, etc), staring at lights, and decoupled visual and motor functions (looking away while reaching), in addition to decreased visual acuity and visual field deficits.8 Colour vision may be relatively preserved.9 Later investigators have described other visual deficits, such as difficulties with recognising faces (prosopagnosia) or objects, depth perception, multiple objects (simultanagnosia), motion perception and visuospatial orientation.7 10 Because of the myriad of abnormalities of visual behaviours and deficits displayed by children with CVI, no single test has been universally accepted to characterise CVI severity.11 However, a method of quantifying visual function and functional vision in CVI is necessary for both clinical practice and research. In clinical practice, such a measure would enable longitudinal assessments of a child’s progress and could potentially inform vision services and accommodations. In clinical research, a measure of CVI severity is needed to demonstrate the efficacy of proposed interventions in a controlled trial. Currently, there is no standard treatment for children with CVI.1 Vision services are region-dependent, and children with CVI often receive generic accommodations designed for patients with ocular causes of visual impairment.
Psychophysical measures of visual function in CVI include preferential looking tests and sweep visual evoked potentials (VEPs). Due to neurological deficits and developmental delays, many children with CVI are unable to cooperate with optotype acuity testing.11 In these children, visual acuity may be estimated using preferential looking methods, such as Teller acuity.12 Electrophysiology, particularly sweep VEP, may also estimate visual acuity in non-verbal children with CVI.13 However, these measures do not capture the breadth of deficits in visual functioning exhibited by children with CVI.
More comprehensive measures of visual function in CVI include neuropsychological tests and eye tracking. Neuropsychological tests of visual perception, such as the Children’s Visual Impairment Test (CVIT) 3–6, are rigorously developed and tested but may be applicable to a limited subset of children with CVI who are able to understand and respond to questions (CVIT 3–6 is indicated for children between developmental ages of 3 years and 6 years).14 15 Eye tracking shows promise as an objective method of quantifying multiple aspects of visual function in children with CVI, but research is still ongoing to validate this technique.16 17
The CVI Range is a behavioural assessment of functional vision (the ability to interpret and react to visual information) administered by certified examiners, typically teachers for the visually impaired.18 Through a combination of observation, parent interview and direct assessment, the examiner grades the child on 10 characteristics of CVI (box 1), which function as subscales or domains of the total CVI Range score. There are two methods of calculating the CVI Range score: across-CVI and within-CVI Characteristics. CVI Range scores range from 0 to 10, with 10 indicating the best functional vision. The scores are further divided into three phases (phase I: 0–3, phase II: 4–7 and phase III: 8–10; figure 1). The reliability of the CVI Range was evaluated in a thesis by Newcomb.19 Of 104 children included in the study, 27 underwent CVI Range testing by two different examiners to assess inter-rater reliability, and 20 underwent CVI Range testing twice by the same examiner (within 14 days) to assess test–retest reliability. All 104 children were included in the analysis of internal consistency. Newcomb reported excellent test–retest reliability (Pearson’s r=0.99) and inter-rater reliability (r=0.98) of the within-CVI characteristics method of scoring the CVI Range. Internal consistency was also excellent (Cronbach’s α=0.962). There was excellent agreement between the across-CVI and within-CVI characteristics methods of scoring (κ=0.88). However, this study was judged to be poor quality by the Consensus-based Standards for the Selection of Health Measurement Instruments criteria,20 21 likely due to lack of masking and standardisation of test administration, as the children were variably evaluated at home or school.
Ten characteristics evaluated on the CVI Range
Colour preference.
Need for movement.
Visual latency.
Visual field preferences.
Difficulties with visual complexity.
Need for light.
Difficulty with distance viewing.
Atypical visual reflexes.
Difficulty with visual novelty.
Absence of visually guided reach.
The purpose of this study is to evaluate the reliability and validity of the CVI Range in a clinical research environment (CVI Range–Clinical Research (CVI Range-CR)). This modified version of the CVI Range is a semistructured assessment that can be administered in a controlled setting using a defined set of materials. The CVI Range-CR is designed to enable remote grading by video recordings and therefore may be applicable to multicentre clinical trials requiring a centralised remote grader.